SCHEMBL25654970

SCHEMBL25654970

CS1(C)c2ccccc2N(c2ccc(N3c4ccccc4S(C)(C)c4ccccc43)c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TSHR P16473 3/20 0.33
▸ LMNA P02545 5/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ MAPT P10636 4/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24408587 0.88 L3MBTL1 (0.36) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL25655100 0.86 L3MBTL1 (0.34) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL25654981 0.86 L3MBTL1 (0.34) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL25577415 0.86 L3MBTL1 (0.34) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL25655308 0.85 L3MBTL1 (0.33) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL24408758 0.83 L3MBTL1 (0.32) L3MBTL1LMNAMAPTMEN1KMT2A
SCHEMBL24408645 0.83 TSHR (0.34) L3MBTL1TSHRLMNAHRH4POLB
SCHEMBL22514676 0.81 L3MBTL1 (0.36) L3MBTL1TSHRLMNAPOLBADORA3
SCHEMBL22514719 0.80 L3MBTL1 (0.35) L3MBTL1TSHRLMNAPOLBADORA3
SCHEMBL22514671 0.79 HDAC6 (0.41) L3MBTL1TSHRLMNAPOLBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, AOX1 L3MBTL1 650/4885TSHR 3675/4885LMNA 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback